Meritage Group’s Thermo Fisher Scientific TMO Stock Holding History

Meritage Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-821,795	Closed	-$267M	–	45
2019 Q4	$267M	Sell	821,795 -88,162	-10%	-$26.7M	4.69%	8
2019 Q3	$265M	Buy	909,957 +189,478	+26%	+$54.3M	4.96%	9
2019 Q2	$212M	Hold	720,479	–	–	3.7%	10
2019 Q1	$197M	Buy	720,479 +2,351	+0.3%	+$585K	4.19%	10
2018 Q4	$161M	Sell	718,128 -166,868	-19%	-$39.2M	3.8%	15
2018 Q3	$216M	Sell	884,996 -78,433	-8%	-$18M	3.36%	9
2018 Q2	$200M	Sell	963,429 -95,556	-9%	-$20.3M	3.34%	11
2018 Q1	$219M	Sell	1,058,985 -16,990	-2%	-$3.57M	3.81%	8
2017 Q4	$204M	Buy	1,075,975 +11,581	+1%	+$2.22M	3.43%	8
2017 Q3	$201M	Buy	+1,064,394	New	+$193M	3.66%	9

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Meritage Group's TMO Position: Q1 2020 in Review

Meritage Group sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 821,795 shares — an estimated $267M sold.

Meritage Group first reported a position in TMO in Q3 2017 and held it in 10 quarters. The position peaked at $267M in Q4 2019. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

Meritage Group reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
Meritage Group sold 821,795 Thermo Fisher Scientific shares in Q1 2020, an estimated $267M.
Meritage Group first reported a position in Thermo Fisher Scientific in Q3 2017 and held it in 10 quarters.
Meritage Group's Thermo Fisher Scientific position peaked at $267M in Q4 2019.
1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Meritage Group's 13F filing for Q1 2020, filed 14 May 2020.